About Cipesta 500mg
Cipesta 500mg Tablet is helpful for the treatment of infections caused by bacteria. It contains ciprofloxacin as an active ingredient and belongs to a group of medicines known as fluoroquinolone. Cipesta 500mg is useful in the process of dealing with patients with low white blood cell counts (neutropenia) who have a fever that is suspected to be due to a bacterial infection.
How effective is Cipesta 500mg?
Cipesta 500mg Tablet is helpful to control, prevent, and improve the following diseases, conditions, and symptoms like respiratory tract infection, sinus, urinary tract, genital tract, gastrointestinal tract, intra-abdominal, skin and soft tissue, and bone and joint infections. Cipesta 500mg works by killing bacteria that cause infections.
What dose should I choose?
For adults (ages 18 years and older), take an oral dosage of 2 tablets in a single day.
For children (below 17 years), this medicine is not recommended. It is not helpful for people under 18 years.
Try not to exceed the given dosage. If you have any medication queries, consult with your doctor or a pharmacist.
What are the side effects and other warnings when taking Cipesta 500mg?
All products with an active ingredient can cause side effects, although they are rare.
Side effects can include:
- Muscle weakness.
- Usual feelings of pain.
- Burning tingling.
- Numbness.
- Muscle weakness in the extremities (neuropathy).
These effects tend to be temporary and may disappear when your body gets adjusted according to this medication. You should stop the use immediately and consult your doctor or a pharmacist if an allergic reaction occurs.
Symptoms of an allergy include:
- Rash
- Itching/ swelling
- Severe dizziness
- Trouble breathing.
If you are pregnant, might become pregnant, or think you may be pregnant or breast-feeding or planning to breast-feed, notify your doctor or a pharmacist before using this product.
If you have any concerns about any potential side effects, please speak to the experts.
Reviews
Clear filtersThere are no reviews yet.